<!DOCTYPE html>
<html>
<head>
    <title>全文阅读--XML全文阅读--中国知网</title>
    <link rel="icon" href="/kxreader/favicon.ico" />
    <link rel="shortcut Icon" href="/kxreader/favicon.ico" />
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
    <meta name="keywords" content="文献 XML KBASE CNKI 中国知网" />
    <meta name="description" content="XML文献检索" />
    <link href="/kxreader/Content/css/detail?v=NOOK-mvTMnxl11s6oPYV0boPXN3iP4N7Rc-A56nk4KI1" rel="stylesheet"/>

    <script type="text/javascript">
        var APPPATH = '/kxreader';
    </script>
</head>

<body>
    
<script type="text/javascript" src="//login.cnki.net/TopLogin/api/loginapi/get?type=top&amp;localCSS=&amp;returnurl=%2f%2fkns.cnki.net%2fKXReader%2fDetail%3fTIMESTAMP%3d637141665403857500%26DBCODE%3dCJFD%26TABLEName%3dCJFDLAST2019%26FileName%3dXXGK201904017%26RESULT%3d1%26SIGN%3dGDR1WBhdaFOi3APznUBLMwLHeI0%253d"></script>

<div id="headerBox" class="header">
    <div class="topbar">
        <div class="textalign">
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=XXGK201904017&amp;align=md">
                <i class="icon-cen active" title="居中对齐"></i>
            </a>
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=XXGK201904017&amp;align=lt">
                <i class="icon-left " title="左对齐"></i>
            </a>
        </div>
        <h6 class="free-tip"><i class="icon"></i>HTML阅读开放试用阶段，欢迎体验！</h6>
    </div>
</div>

    



<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201904017&amp;v=MDIzNjg2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpuVjdyS1BUWE1aYkc0SDlqTXE0OUVZNFFLREg4NHZSNFQ=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>

    <div class="main">

        

    <div class="sidebar-a">
        <!--sidebar start-->
        <div class="sidenav">
            <div class="arrow"><span></span></div>
            <!--sidebar_list start-->
            <dl class="sidenav-list">
                    <dt class="tit">目录结构</dt>
                            <dd class="guide">
                                    <p><a href="#34" data-title="&lt;b&gt;1 资料与方法&lt;/b&gt; "><b>1 资料与方法</b></a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#35" data-title="1.1 一般资料">1.1 一般资料</a></li>
                                                <li><a href="#38" data-title="1.2 治疗方法">1.2 治疗方法</a></li>
                                                <li><a href="#40" data-title="1.3 EPCs的流式细胞仪检测">1.3 EPCs的流式细胞仪检测</a></li>
                                                <li><a href="#42" data-title="1.4 临床观察指标">1.4 临床观察指标</a></li>
                                                <li><a href="#44" data-title="1.5 统计分析">1.5 统计分析</a></li>
                                    </ul>
                            </dd>
                            <dd class="guide">
                                    <p><a href="#47" data-title="&lt;b&gt;2 结 果&lt;/b&gt; "><b>2 结 果</b></a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#48" data-title="2.1 治疗前、治疗28d后两组外周血EPCs的比例变化">2.1 治疗前、治疗28d后两组外周血EPCs的比例变化</a></li>
                                                <li><a href="#51" data-title="2.2 两组治疗前、治疗6个月后心脏超声临床指标的变化">2.2 两组治疗前、治疗6个月后心脏超声临床指标的变化</a></li>
                                                <li><a href="#55" data-title="2.3 两组治疗期间临床不良反应的比较">2.3 两组治疗期间临床不良反应的比较</a></li>
                                    </ul>
                            </dd>
                            <dd class="guide">
                                    <p><a href="#57" data-title="&lt;b&gt;3 讨 论&lt;/b&gt; "><b>3 讨 论</b></a><i></i></p>
                                                            </dd>
                            <dd class="guide">
                                    <p><a href="#" data-title="文内图表 ">文内图表</a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#37" data-title="&lt;b&gt;表&lt;/b&gt;1 &lt;b&gt;两组一般临床资料的比较&lt;/b&gt; (n=64) "><b>表</b>1 <b>两组一般临床资料的比较</b> (n=64) </a></li>
                                                <li><a href="#50" data-title="&lt;b&gt;表&lt;/b&gt;2 &lt;b&gt;两组治疗前、治疗&lt;/b&gt;28d&lt;b&gt;后外周血&lt;/b&gt;EPCs&lt;b&gt;的比较&lt;/b&gt; (n=64) "><b>表</b>2 <b>两组治疗前、治疗</b>28d<b>后外周血</b>EPCs<b>的比较</b> (n=64) </a></li>
                                                <li><a href="#53" data-title="表3 两组治疗前、治疗6个月后LVEF、LVESd和LVEDd的比较（&lt;image id=&quot;77&quot; type=&quot;formula&quot; href=&quot;images/XXGK201904017_07700.jpg&quot; display=&quot;inline&quot; placement=&quot;inline&quot;&gt;&lt;alt&gt;&lt;/alt&gt;&lt;/image&gt;&#177;s，n=64) ">表3 两组治疗前、治疗6个月后LVEF、LVESd和LVEDd的比较（<image id="77" type="formula" href="images/XXGK201904017_07700.jpg" display="inline" placement="inline"><alt></alt></image>±s，n=64) </a></li>
                                    </ul>
                            </dd>
                                    <dd class="guide">
                                        <h6>
                                            <p><a href="#a_bibliography">参考文献</a> </p>
                                        </h6>
                                    </dd>

            </dl>
        </div>
        <!--sidebar end-->
        &nbsp;
        <!--此处有一空格符 勿删-->
    </div>

                <div class="sidebar-b three-collumn" style="width:0;">
            <div class="refer" style="width: 0;">
                <div class="arrow off" title="参考文献"><span></span></div>
                <div class="js-scrollbox" >
                    
                    <div class="subbox active">
                        <h4>
                            <span class="tit">参考文献</span>
                            <a class="close" href="javascript:void(0)">x</a>
                        </h4>
                        <div class="side-scroller">
                            <ul class="refer-list">
                                <li id="5">


                                    <a id="bibliography_1" title="葛水秀.瑞舒伐他汀对急性心肌梗死大鼠心肌细胞保护作用及RhoA/ROCK活化机制[J].心脑血管病防治, 2018, 18 (2) :98-101, 172." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXFZ201802005&amp;v=Mjg2OTJyWTlGWVlRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqblY3cktQVFhOZExHNEg5bk0=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[1]</b>
                                        葛水秀.瑞舒伐他汀对急性心肌梗死大鼠心肌细胞保护作用及RhoA/ROCK活化机制[J].心脑血管病防治, 2018, 18 (2) :98-101, 172.
                                    </a>
                                </li>
                                <li id="7">


                                    <a id="bibliography_2" title="Regueiro A, Cuadrado-Godia E, Bueno-Bet&#237; C, et al.Mobilization of endothelial progenitor cells in acute Cardiovasc events in the PROCELL study:time-course after acute myocardial infarction and stroke[J].J Mol Cell Cardiol, 2015, 80:146-155." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES15121200435534&amp;v=MjE0MjViSzlIOVBOclk5RllPZ0tDWDg5b0JNVDZUNFBRSC9pclJkR2VycVFUTW53WmVadEZpbmxVcmZJSUZ3UWJ4QT1OaWZPZg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[2]</b>
                                        Regueiro A, Cuadrado-Godia E, Bueno-Bet&#237; C, et al.Mobilization of endothelial progenitor cells in acute Cardiovasc events in the PROCELL study:time-course after acute myocardial infarction and stroke[J].J Mol Cell Cardiol, 2015, 80:146-155.
                                    </a>
                                </li>
                                <li id="9">


                                    <a id="bibliography_3" title="李中轩, 张颖倩, 陈韵岱.内皮祖细胞在缺血性心脏病治疗中的研究进展[J].中国循证心血管医学杂志, 2017, 9 (7) :873-875, 878." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=PZXX201707039&amp;v=MTA1NTVuVjdyS05UZlRkckc0SDliTXFJOUdiWVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWo=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[3]</b>
                                        李中轩, 张颖倩, 陈韵岱.内皮祖细胞在缺血性心脏病治疗中的研究进展[J].中国循证心血管医学杂志, 2017, 9 (7) :873-875, 878.
                                    </a>
                                </li>
                                <li id="11">


                                    <a id="bibliography_4" title="李丹萍.阿托伐他汀与瑞舒伐他汀治疗急性心肌梗死患者的临床效果以及安全性比较[J].中国现代药物应用, 2018, 12 (13) :102-103." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZWYY201813057&amp;v=MDM0MzQ5QVk0UUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am5WN3JLUHpyU2Q3RzRIOW5Ockk=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[4]</b>
                                        李丹萍.阿托伐他汀与瑞舒伐他汀治疗急性心肌梗死患者的临床效果以及安全性比较[J].中国现代药物应用, 2018, 12 (13) :102-103.
                                    </a>
                                </li>
                                <li id="13">


                                    <a id="bibliography_5" title="张兵.瑞舒伐他汀对稳定性冠心病患者内皮祖细胞的影响[J].牡丹江医学院学报, 2018, 39 (3) :47-48, 38." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=MDJB201803013&amp;v=MTY1NDl1Wm1GeWpuVjdyS0tDbkJiTEc0SDluTXJJOUVaNFFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlo=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[5]</b>
                                        张兵.瑞舒伐他汀对稳定性冠心病患者内皮祖细胞的影响[J].牡丹江医学院学报, 2018, 39 (3) :47-48, 38.
                                    </a>
                                </li>
                                <li id="15">


                                    <a id="bibliography_6" title="中华医学会心血管病学分会, 中华心血管病杂志编辑委员会.急性ST段抬高型心肌梗死诊断和治疗指南[J].中华心血管病杂志, 2015, 43 (5) :380-394." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZHXX201505003&amp;v=MDc0NDF5WFRkckc0SDlUTXFvOUZaNFFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpuVjdyS1A=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[6]</b>
                                        中华医学会心血管病学分会, 中华心血管病杂志编辑委员会.急性ST段抬高型心肌梗死诊断和治疗指南[J].中华心血管病杂志, 2015, 43 (5) :380-394.
                                    </a>
                                </li>
                                <li id="17">


                                    <a id="bibliography_7" title="Luo F, Wu P, Chen J, et al.ANGPTL3 possibly promotes cardiac angiogenesis through improving proangiogenic ability of endothelial progenitor cells after myocardial infarction[J].Lipids Health Dis, 2018, 17 (1) :184." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=ANGPTL3 possibly promotes cardiac angiogenesis through improving proangiogenic ability of endothelial progenitor cells after myocardial infarction">
                                        <b>[7]</b>
                                        Luo F, Wu P, Chen J, et al.ANGPTL3 possibly promotes cardiac angiogenesis through improving proangiogenic ability of endothelial progenitor cells after myocardial infarction[J].Lipids Health Dis, 2018, 17 (1) :184.
                                    </a>
                                </li>
                                <li id="19">


                                    <a id="bibliography_8" title="李玉琳, 张言真子, 陈博雅, 等.白细胞介素-12基因缺陷促进内皮祖细胞浸润改善缺血再灌注后心肌损伤的研究[J].心肺血管病杂志, 2018, 37 (7) :677-681, 691." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XFXZ201807023&amp;v=MDk1MTJPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am5WN3JLUFN2VGRMRzRIOW5NcUk5SFo0UUtESDg0dlI0VDZqNTQ=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[8]</b>
                                        李玉琳, 张言真子, 陈博雅, 等.白细胞介素-12基因缺陷促进内皮祖细胞浸润改善缺血再灌注后心肌损伤的研究[J].心肺血管病杂志, 2018, 37 (7) :677-681, 691.
                                    </a>
                                </li>
                                <li id="21">


                                    <a id="bibliography_9" title="Ibanez B, James S, Agewall S, et al.2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation:The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC) [J].Eur Heart J, 2018, 39 (2) :119-177." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation:The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Societ">
                                        <b>[9]</b>
                                        Ibanez B, James S, Agewall S, et al.2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation:The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC) [J].Eur Heart J, 2018, 39 (2) :119-177.
                                    </a>
                                </li>
                                <li id="23">


                                    <a id="bibliography_10" title="王太昊, 岑运光.瑞舒伐他汀片治疗急性心肌梗死的临床研究[J].中国临床药理学杂志, 2018, 34 (7) :756-759." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=GLYZ201807006&amp;v=MzAxNDVSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpuVjdyS0lpSFNkTEc0SDluTXFJOUZZb1FLREg4NHY=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[10]</b>
                                        王太昊, 岑运光.瑞舒伐他汀片治疗急性心肌梗死的临床研究[J].中国临床药理学杂志, 2018, 34 (7) :756-759.
                                    </a>
                                </li>
                                <li id="25">


                                    <a id="bibliography_11" title="夏明红, 胡春光, 吴陈欢.瑞舒伐他汀对急性心肌梗死大鼠心肌细胞凋亡及胱天蛋白酶-3基因表达的影响[J].中国临床药理学杂志, 2018, 34 (2) :134-136." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=GLYZ201802012&amp;v=MTgwNjBJaUhTZExHNEg5bk1yWTlFWm9RS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqblY3cks=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[11]</b>
                                        夏明红, 胡春光, 吴陈欢.瑞舒伐他汀对急性心肌梗死大鼠心肌细胞凋亡及胱天蛋白酶-3基因表达的影响[J].中国临床药理学杂志, 2018, 34 (2) :134-136.
                                    </a>
                                </li>
                                <li id="27">


                                    <a id="bibliography_12" title="朱国腾, 褚现明, 田晶, 等.PCI围手术期瑞舒伐他汀强化治疗对其循环内皮祖细胞数量及功能的影响[J].中国临床研究, 2018, 31 (3) :289-293." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZGCK201803001&amp;v=MjE3MThyS1B5cklaYkc0SDluTXJJOUZaWVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpuVjc=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[12]</b>
                                        朱国腾, 褚现明, 田晶, 等.PCI围手术期瑞舒伐他汀强化治疗对其循环内皮祖细胞数量及功能的影响[J].中国临床研究, 2018, 31 (3) :289-293.
                                    </a>
                                </li>
                                <li id="29">


                                    <a id="bibliography_13" title="谢静, 闵青.瑞舒伐他汀对急性心肌梗死患者PCI术后炎症因子和血液流变学的影响[J].中国循证心血管医学杂志, 2018, 10 (1) :82-84." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=PZXX201801022&amp;v=MDM3NTMzenFxQnRHRnJDVVI3cWZadVptRnlqblY3cktOVGZUZHJHNEg5bk1ybzlIWm9RS0RIODR2UjRUNmo1NE8=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[13]</b>
                                        谢静, 闵青.瑞舒伐他汀对急性心肌梗死患者PCI术后炎症因子和血液流变学的影响[J].中国循证心血管医学杂志, 2018, 10 (1) :82-84.
                                    </a>
                                </li>
                                <li id="31">


                                    <a id="bibliography_14" title="谢亚芹, 赵娟, 康大伟, 等.不同剂量瑞舒伐他汀对急性心肌梗死大鼠心肌纤维化的影响及机制[J].广东医学, 2018, 39 (2) :195-198." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=GAYX201802009&amp;v=MTYxMzlLSWl6U2RyRzRIOW5Nclk5RmJZUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am5WN3I=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[14]</b>
                                        谢亚芹, 赵娟, 康大伟, 等.不同剂量瑞舒伐他汀对急性心肌梗死大鼠心肌纤维化的影响及机制[J].广东医学, 2018, 39 (2) :195-198.
                                    </a>
                                </li>
                            </ul>
                            <div style='display: none;' class="zqscroller" >
                                <h4 class="">附加材料</h4>
                                <ul></ul>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            &nbsp;
            <!--此处有一空格符 勿删-->
        </div>

        
    <div class="content">



        <!--tips start-->
                            <div class="tips">
                    <a href="http://navi.cnki.net/KNavi/JournalDetail?pcode=CJFD&amp;pykm=XXGK" target="_blank">心血管康复医学杂志</a>
                2019,28(04),458-461 DOI:10.3969/j.issn.1008-0074.2019.04.17            </div>
        <!--tips end-->
            <div class="top-title">
                <h1 class="title">
                    <span class="vm"><b>瑞舒伐他汀动员内皮祖细胞对心肌梗死患者心室重构的影响</b></span>
                                    </h1>

            </div>
                        <h2>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E6%9E%97%E4%B9%A6%E6%97%AD&amp;code=37427168&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">林书旭</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E7%8E%8B%E6%81%8B&amp;code=42560803&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">王恋</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E6%BD%98%E5%A6%99%E4%BB%99&amp;code=42560804&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">潘妙仙</a>
                </h2>
                    <h2>
                    <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=in&amp;skey=%E6%B5%B7%E5%8F%A3%E5%B8%82%E7%AC%AC%E4%B8%89%E4%BA%BA%E6%B0%91%E5%8C%BB%E9%99%A2%E5%BF%83%E8%A1%80%E7%AE%A1%E5%86%85%E7%A7%91&amp;code=0935153&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">海口市第三人民医院心血管内科</a>
            </h2>

        
<div class="link">
    <a id="aexport" class="icon icon-output"  onclick="" href="javascript:void(0);"><i></i>导出/参考文献</a>
    
    <span class="shareBoard" onmouseover="$('#sharedet').show();$('#this').addClass('shareBoardCUR')" onmouseout="$('#sharedet').hide();$('#this').removeClass('shareBoardCUR')">
        <a class="icon icon-share" href="#"><i></i>分享<em></em></a>
        <ul class="shareHide" id="sharedet" style="display: none;">
            <li><a title="复制链接" class="copy" onclick="" href="#"><i></i>复制链接</a></li>
            <li><a title="分享到新浪微博" class="xl" onclick="" href="javascript:common.ShareAction('xl');"><i></i>新浪微博</a></li>
            <li>
                <a title="分享到微信" class="wx" onclick="" href="#"><i></i>微信扫一扫</a>
                <div class="qrcode"><img src='' alt='' /></div>
            </li>
        </ul>

    </span>
    
    <a id="RefTrack" title="创建引文跟踪" class="icon icon-track" onclick="" href="javascript:void(0);"> <i></i>创建引文跟踪 </a>
    <a id="ashoucang" title="收藏" class="icon icon-favor" onclick="" href="javascript:void(0);"><i></i>收藏</a>
    <a class="icon icon-print" onclick="window.print();" href="javascript:void(0);"><i></i>打印</a>
    
    <!--版本切换 end-->
</div>
                            <div class="data" id="a_abstract">
                <span class="keys">摘<span style="font-family: 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;</span>要：</span>
                <p><b>目的</b>:观察心肌梗死 (MI) 患者使用瑞舒伐他汀后对内皮祖细胞 (EPCs) 的动员作用, 以及其对心室重构的影响。<b>方法</b>:选择2017年1月至2018年1月于我科接受PCI治疗的MI患者128例。患者被随机均分为常规治疗组和瑞舒伐他汀组 (在常规治疗组基础上加用瑞舒伐他汀) , 两组均连续治疗28d。测量比较两组治疗前、28d后的外周血EPCs比例, 治疗前、结束6个月后LVEF、左室收缩末期内径 (LVESd) 、左室舒张末期内径 (LVEDd) 以及不良反应率。<b>结果</b>:与治疗前比较, 治疗28d后瑞舒伐他汀组外周血EPCs比例[ (0.64±0.15) %比 (1.08±0.23) %]显著升高, <i>P</i>=0.001;且显著高于常规治疗组[ (1.08±0.23) %比 (0.58±0.12) %], <i>P</i>=0.001。与治疗前比较, 两组治疗结束6个月后LVEF均显著升高, LVESd和LVEDd均显著降低, <i>P</i>均=0.001;与常规治疗组比较, 瑞舒伐他汀组LVEF[ (52.24±7.18) %比 (58.36±8.62) %]升高更显著, LVESd[ (33.46±5.04) mm比 (30.26±4.15) mm]和LVEDd[ (56.17±8.24) mm比 (51.38±7.62) mm]降低更显著, <i>P</i>均=0.001。两组不良反应发生率无显著差异, <i>P</i>=0.752。<b>结论</b>:瑞舒伐他汀可以增加心肌梗死患者内皮祖细胞动员, 抑制心室重构, 显著改善心功能, 使用安全, 值得推广。</p>
            </div>
                    <div class="data" id="a_keywords">
                <span class="keys">关键词：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E5%BF%83%E8%82%8C%E6%A2%97%E6%AD%BB&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">心肌梗死;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E5%BF%83%E5%AE%A4%E9%87%8D%E6%9E%84&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">心室重构;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E7%91%9E%E8%88%92%E4%BC%90%E4%BB%96%E6%B1%80&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">瑞舒伐他汀;</a>
                </p>
            </div>
        
        <!--brief start-->
        
            <div class="brief">
                    <p>
                                            </p>
                                    <p><b>收稿日期：</b>2018-09-03</p>

            </div>
                    <h1>Influence of endothelial progenitor cells mobilized by rosuvastatin on ventricular remodeling in patients with myocardial infarction</h1>
                    <h2>
                    <span>LIN Shu-xu</span>
                    <span>WANG Lian</span>
                    <span>PAN Miao-xian</span>
            </h2>
                    <h2>
                    <span>Department of Cardiology, Third People's Hospital of Haikou City</span>
            </h2>
                            <div class="data" id="a_abstractEN">
                <span class="keys">Abstract：</span>
                <p><b>Objective</b>:To observe influence of endothelial progenitor cells (EPCs) mobilized by rosuvastatin on ventricular remodeling in patients with myocardial infarction (MI) . <b>Methods</b>:A total of 128 MI patients received PCI treated in our department from Jan 2017 to Jan 2018 were selected, randomly and equally divided into routine treatment group and rosuvastatin group (received rosuvastatin based on routine treatment group) , both groups were continuously treated for 28 d. Peripheral blood percentage of EPCs before and 28 d after treatment, LVEF, LVESd and LVEDd before and six months after treatment, and incidence rate of adverse reactions were measured and compared between two groups. <b>Results</b>:Compared with before treatment, there was significant rise in peripheral blood percentage of EPCs [ (0.64±0.15) % vs. (1.08±0.23) %] in only rosuvastatin group on 28 d after treatment, <i>P</i>=0.001; and was significantly higher than that of routine treatment group [ (1.08±0.23) % vs. (0.58±0.12) %], <i>P</i>=0.001. Compared with before treatment, there was significant rise in LVEF, and significant reductions in LVEDd and LVESd in two groups on six months after treatment, <i>P</i>=0.001 all; compared with routine treatment group, there was significant rise in LVEF[ (52.24±7.18) % vs. (58.36±8.62) %], and significant reductions in LVESd[ (33.46±5.04) mm vs. (30.26±4.15) mm] and LVEDd [ (56.17± 8.24) mm vs. (51.38±7.62) mm] in rosuvastatin group, <i>P</i>=0.001 all. There was no significant difference in incidence rate of adverse reactions between two groups, <i>P</i>=0.752. <b>Conclusion</b>:Rosuvastatin can mobilize EPCs to inhibit ventricular remodeling, significantly improve cardiac function with good safety in patients with myocardial infarction, which is worth extending.</p>
            </div>
                    <div class="data" id="a_keywordsEN">
                <span class="keys">Keyword：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Myocardial%20infarction&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Myocardial infarction;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Ventricular%20remodeling&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Ventricular remodeling;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Rosuvastatin&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Rosuvastatin;</a>
                </p>
            </div>
                    <div class="brief">
                
                    <p>
                                            </p>
                                    <p><b>Received：</b> 2018-09-03</p>
                            </div>


        <!--brief start-->
                        <div class="p1">
                    <p id="33">心肌梗死 (MI) 是常见的心血管系统疾病, 冠状动脉闭塞血流中断, 心肌坏死, 后续的纤维修复会导致心肌重构、纤维化甚至发展为慢性心力衰竭<citation id="61" type="reference"><link href="5" rel="bibliography" /><sup>[<a class="sup">1</a>]</sup></citation>。MI的临床治疗不仅仅是快速恢复血供, 预防缺血再灌注损伤, 对于后期心功能的保护也正逐渐受到临床工作者们的关注<citation id="62" type="reference"><link href="7" rel="bibliography" /><sup>[<a class="sup">2</a>]</sup></citation>。内皮祖细胞 (Endothelial progenitor cells, EPCs) 是血管内皮细胞前体细胞, 研究发现心肌梗死早期外周血液循环中EPCs比例代偿性升高, 参与缺血区血管再生, 有利于远期受损心功能的恢复<citation id="63" type="reference"><link href="9" rel="bibliography" /><sup>[<a class="sup">3</a>]</sup></citation>。瑞舒伐他汀是一种羟甲基戊二酸单酰辅酶A (HMG-CoA) 还原酶抑制剂, 抑制胆固醇合成的限速酶和上调低密度脂蛋白 (LDL) 受体, 加速LDL代谢, 临床主要用于降脂, 但近期的研究显示瑞舒伐他汀可以通过抑制炎症反应、保护血管内皮等机制参与受损心肌的修复<citation id="64" type="reference"><link href="11" rel="bibliography" /><sup>[<a class="sup">4</a>]</sup></citation>, 在冠心病的患者中使用瑞舒伐他汀, 发现EPCs动员增加<citation id="65" type="reference"><link href="13" rel="bibliography" /><sup>[<a class="sup">5</a>]</sup></citation>。本研究观察了MI患者使用瑞舒伐他汀后对EPCs的动员作用, 以及其对心肌重构的影响。</p>
                </div>
                <h3 id="34" name="34" class="anchor-tag"><b>1 资料与方法</b></h3>
                <h4 class="anchor-tag" id="35" name="35">1.1 一般资料</h4>
                <div class="p1">
                    <p id="36">选择2017年1月至2018年1月于海口市第三人民医院心血管内科接受治疗的MI患者128例。纳入标准:符合《急性ST段抬高型心肌梗死诊断和治疗指南 (2015年) 》诊断标准<sup></sup><citation id="66" type="reference"><link href="15" rel="bibliography" /><sup>[<a class="sup">6</a>]</sup></citation>。排除标准:伴发肝、脑、肺、肾等重要脏器严重功能障碍患者;伴发先天性心脏病、瓣膜病、心肌病患者, 伴发难以控制的严重心律失常, 伴发严重的心力衰竭, 心功能NYHA分级&gt;Ⅲ级患者, 伴发难以控制的感染、肿瘤或者免疫性疾病患者。入组的128例患者按照数字表法被随机均分为常规治疗组和瑞舒伐他汀组, 每组64例。两组一般临床资料差异无统计学意义 (<i>P</i>均&gt;0.05) , 具有可比性, 见表1。</p>
                </div>
                <div class="area_img" id="37">
                    <p class="img_tit"><b>表</b>1 <b>两组一般临床资料的比较</b> (n=64)  <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="37" border="1"><tr><td><br />组别</td><td>男/女<br /> (例) </td><td>年龄<br /> (岁) </td><td>甘油三酯<br /> (μmol/L) </td><td>总胆固醇<br /> (μmol/L) </td></tr><tr><td><br />常规治疗组</td><td>34/30</td><td>66.45±10.23</td><td>1.82±0.35</td><td>4.63±1.07</td></tr><tr><td><br />瑞舒伐他汀组</td><td>35/29</td><td>66.62±10.38</td><td>1.84±0.37</td><td>4.61±1.12</td></tr><tr><td><br /><i>t</i>/<i>χ</i><sup>2</sup></td><td>0.031</td><td>0.093</td><td>0.314</td><td>0.103</td></tr><tr><td><br /><i>P</i></td><td>0.860</td><td>0.926</td><td>0.754</td><td>0.918</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note"></p>
                    <p class="img_note"></p>
                </div>
                <h4 class="anchor-tag" id="38" name="38">1.2 治疗方法</h4>
                <div class="p1">
                    <p id="39">常规治疗组:患者入院后给予经皮冠状动脉介入治疗 (PCI) , 术后维持盐酸替罗非班抗凝以及常规基础治疗。瑞舒伐他汀组:在常规治疗组基础上加用瑞舒伐他汀钙片 (英国 Astra Zeneca 公司, 批号20161203) 口服, 10 mg/d, 两组疗程均为28d, 28d后两组均改为口服100 mg/d阿司匹林肠溶片, 持续6个月。</p>
                </div>
                <h4 class="anchor-tag" id="40" name="40">1.3 EPCs的流式细胞仪检测</h4>
                <div class="p1">
                    <p id="41">所有患者治疗前和治疗28d结束后, 抽取抗凝静脉血5ml, 加入等体积的单个核细胞分离液, 1500r/min 离心20min, 抽取中间层的单个核细胞, 流式细胞仪检测其中EPCs所占比例。PE-VEGFR-2、APC-CD133荧光标记抗体购自美国millopore公司, 按照抗体试剂盒说明书, 加入相关抗体, 并设置同型对照, EPICS-XL流式细胞仪 (美国 Beckman-Coulter 公司) 检测以及机器自带的FCM 软件分析CD133和VEGFR-2双阳性的EPCs细胞比例。</p>
                </div>
                <h4 class="anchor-tag" id="42" name="42">1.4 临床观察指标</h4>
                <div class="p1">
                    <p id="43">治疗前和治疗6个月后, 采用美国惠普公司Sonos5500型超声诊断仪, 探头频率 2～4 MHz, 检测左室射血分数 (LVEF) 、左心室收缩末期内径 (LVESd) 、左心室舒张末期内径 (LVEDd) 。记录用药期间的药物相关不良作用。</p>
                </div>
                <h4 class="anchor-tag" id="44" name="44">1.5 统计分析</h4>
                <div class="p1">
                    <p id="45">使用SPSS 18.0统计软件处理, 计量资料以均数±标准差 (<image id="75" type="formula" href="images/XXGK201904017_07500.jpg" display="inline" placement="inline"><alt></alt></image>±s) 表示, 比较采用<i>t</i>检验, 计数资料以百分率表示, 比较采用<i>χ</i><sup>2</sup>检验。<i>P</i>&lt;0.05为统计学有显著性差异。</p>
                </div>
                <h3 id="47" name="47" class="anchor-tag"><b>2 结 果</b></h3>
                <h4 class="anchor-tag" id="48" name="48">2.1 治疗前、治疗28d后两组外周血EPCs的比例变化</h4>
                <div class="p1">
                    <p id="49">治疗前两组EPCs比例无显著性差异 (<i>P</i>=0.437) ;治疗28d后常规治疗组EPCs比例无显著变化 (<i>P</i>=0.085) , 但瑞舒伐他汀组EPCs比例显著升高, 且显著高于常规治疗组 (<i>P</i>均=0.001) 。见表2。</p>
                </div>
                <div class="area_img" id="50">
                    <p class="img_tit"><b>表</b>2 <b>两组治疗前、治疗</b>28d<b>后外周血</b>EPCs<b>的比较</b> (n=64)  <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="50" border="1"><tr><td><br />组别</td><td>治疗前<br /> (%) </td><td>治疗28d后<br /> (%) </td><td><i>t</i>/<i>P</i></td></tr><tr><td><br />常规治疗组</td><td>0.62±0.14</td><td>0.58±0.12</td><td>1.735/0.085</td></tr><tr><td><br />瑞舒伐他汀组</td><td>0.64±0.15</td><td>1.08±0.23<sup>**△△</sup></td><td>12.819/0.001</td></tr><tr><td><br /><i>t</i>/<i>P</i></td><td>0.780/0.437</td><td>15.419/0.001</td><td></td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note">注:EPCs:内皮祖细胞。与治疗前比较*<i>P</i>&lt;0.05, **<i>P</i>&lt;0.01;与常规治疗组比较△<i>P</i>&lt;0.05, △△<i>P</i>&lt;0.01。下表同。</p>
                    <p class="img_note"></p>
                </div>
                <h4 class="anchor-tag" id="51" name="51">2.2 两组治疗前、治疗6个月后心脏超声临床指标的变化</h4>
                <div class="p1">
                    <p id="52">治疗前两组LVEF、LVESd和LVEDd差异无显著性 (<i>P</i>均&gt;0.05) , 治疗6个月后两组LVEF均显著升高, LVESd和LVEDd均显著减小 (<i>P</i>均=0.001) , 且瑞舒伐他汀组LVEF显著高于常规治疗组, LVESd和LVEDd显著低于常规治疗组 (<i>P</i>均=0.001) 。见表3。</p>
                </div>
                <div class="area_img" id="53">
                    <p class="img_tit">表3 两组治疗前、治疗6个月后LVEF、LVESd和LVEDd的比较（<image id="77" type="formula" href="images/XXGK201904017_07700.jpg" display="inline" placement="inline"><alt></alt></image>±s，n=64)  <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="53" border="1"><tr><td rowspan="2"><br />组别</td><td colspan="3"><br />LVEF (%) </td><td colspan="3">LVESd (mm) </td><td colspan="3">LVEDd (mm) </td></tr><tr><td>治疗前</td><td>治疗后6个月</td><td><i>t</i>/<i>P</i></td><td>治疗前</td><td>治疗后6个月</td><td><i>t</i>/<i>P</i></td><td>治疗前</td><td>治疗后6个月</td><td><i>t</i>/<i>P</i></td></tr><tr><td>常规治疗组</td><td>41.32±<br />5.23</td><td>52.24±<br />7.18<sup>**</sup></td><td>9.835/0.001</td><td>42.73±<br />6.52</td><td>33.46±<br />5.04<sup>**</sup></td><td>8.999/0.001</td><td>64.18±<br />10.36</td><td>56.17±<br />8.24<sup>**</sup></td><td>4.841/0.001</td></tr><tr><td><br />瑞舒伐他汀组</td><td>41.45±<br />5.27</td><td>58.36±<br />8.62<sup>**△△</sup></td><td>13.390/0.001</td><td>42.86±<br />6.57</td><td>30.26±<br />4.15<sup>**△△</sup></td><td>12.971/0.001</td><td>64.23±<br />10.45</td><td>51.38±<br />7.62<sup>**△△</sup></td><td>7.949/0.001</td></tr><tr><td><br /><i>t</i>/<i>P</i></td><td>0.140/0.889</td><td>4.364/0.001</td><td></td><td>0.112/0.911</td><td>3.921/0.001</td><td></td><td>0.027/0.979</td><td>3.414/0.001</td><td></td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note">注:LVEF:左室射血分数, LVESd:左心室收缩末期内径, LVEDd:左心室舒张末期内径。</p>
                    <p class="img_note"></p>
                </div>
                <h4 class="anchor-tag" id="55" name="55">2.3 两组治疗期间临床不良反应的比较</h4>
                <div class="p1">
                    <p id="56">常规治疗组恶心1例、呕吐1例、头晕1例、腹痛1例, 腹泻1例, 不良反应发生率为7.8% (5/64) , 瑞舒伐他汀组恶心2例、头痛2例、便秘2例, 不良反应发生率为9.4% (6/64) , 两组不良反应发生率无显著性差异 (<i>χ</i><sup>2</sup>=0.100, <i>P</i>=0.752) 。</p>
                </div>
                <h3 id="57" name="57" class="anchor-tag"><b>3 讨 论</b></h3>
                <div class="p1">
                    <p id="58">EPCs是一种多潜能骨髓来源干细胞, 在心肌缺血时会一过性动员增加, 向血管内皮细胞分化, 参与血管新生及损伤内皮的修复<citation id="67" type="reference"><link href="17" rel="bibliography" /><sup>[<a class="sup">7</a>]</sup></citation>, 研究显示增加EPCs动员, 可以抑制缺血心肌的重构, 改善心功能<citation id="68" type="reference"><link href="19" rel="bibliography" /><sup>[<a class="sup">8</a>]</sup></citation>。心肌梗死最主要的原因是冠状动脉粥样硬化, 因此使用他汀类作为调脂药物, 2017 的ST段抬高型心肌梗死 (STEMI) 指南提出心肌梗死时, 如无禁忌证应尽早使用高强度他汀类药物治疗, 并且长期维持使用<citation id="69" type="reference"><link href="21" rel="bibliography" /><sup>[<a class="sup">9</a>]</sup></citation>。王太昊等<citation id="70" type="reference"><link href="23" rel="bibliography" /><sup>[<a class="sup">10</a>]</sup></citation>的临床研究已经显示急性心肌梗死患者中使用瑞舒伐他汀治疗可以显著提高疗效, 夏明红等<citation id="71" type="reference"><link href="25" rel="bibliography" /><sup>[<a class="sup">11</a>]</sup></citation>的急性心肌梗死大鼠模型显示瑞舒伐他汀可以抑制心肌细胞的凋亡, 发挥心肌保护作用, 朱国腾等<citation id="72" type="reference"><link href="27" rel="bibliography" /><sup>[<a class="sup">12</a>]</sup></citation>研究发现瑞舒伐他汀强化治疗可以显著增加PCI围手术期外周血中EPCs数量, 本研究也发现了瑞舒伐他汀组患者外周血EPCs比例显著高于常规治疗组, 说明了瑞舒伐他汀有利于心肌梗死患者外周血EPCs动员增加。</p>
                </div>
                <div class="p1">
                    <p id="59">急性心肌梗死后心室重构是患者后期发展为慢性心功能不全的主要原因, 瑞舒伐他汀在发挥调脂效果时对心血管事件有降低和预防作用<citation id="73" type="reference"><link href="29" rel="bibliography" /><sup>[<a class="sup">13</a>]</sup></citation>。谢亚芹等<citation id="74" type="reference"><link href="31" rel="bibliography" /><sup>[<a class="sup">14</a>]</sup></citation>使用急性心肌梗死大鼠模型显示瑞舒伐他汀可以抑制C反应蛋白 (CRP) 、白介素 (IL) -6、肿瘤坏死因子 (TNF) -α炎症介质的释放, 降低心肌纤维化, 改善心室功能。LVEDd和LVESd是临床上检测心肌重构的重要指标, 本研究显示治疗6月后瑞舒伐他汀组LVEDd和LVESd显著低于常规治疗组, 而且瑞舒伐他汀组LVEF显著高于常规治疗组, 上述结果说明了瑞舒伐他汀可以抑制MI患者心室的重构, 进一步有利于后期心功能的改善。本研究在治疗过程中未发现影响治疗的严重不良反应发生, 所有的不良反应患者均能耐受, 坚持治疗, 并在停药后消失。</p>
                </div>
                <div class="p1">
                    <p id="60">综上所述, 本研究显示瑞舒伐他汀可以增加MI患者EPCs动员, 抑制心室重构, 显著改善心功能, 临床使用安全, 值得推广。</p>
                </div>

        <!--brief end-->
        
        <!--conten left  end-->
        <!--增强附件-->
        

        <!--reference start-->
            <div class="reference anchor-tag" id="a_bibliography">
                    <h3>参考文献</h3>
                                        <p id="5">
                            <a id="bibliography_1" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXFZ201802005&amp;v=MTI0MjNOZExHNEg5bk1yWTlGWVlRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqblY3cktQVFg=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[1]</b>葛水秀.瑞舒伐他汀对急性心肌梗死大鼠心肌细胞保护作用及RhoA/ROCK活化机制[J].心脑血管病防治, 2018, 18 (2) :98-101, 172.
                            </a>
                        </p>
                        <p id="7">
                            <a id="bibliography_2" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES15121200435534&amp;v=MTYyNzlUNlQ0UFFIL2lyUmRHZXJxUVRNbndaZVp0RmlubFVyZklJRndRYnhBPU5pZk9mYks5SDlQTnJZOUZZT2dLQ1g4OW9CTQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[2]</b>Regueiro A, Cuadrado-Godia E, Bueno-Betí C, et al.Mobilization of endothelial progenitor cells in acute Cardiovasc events in the PROCELL study:time-course after acute myocardial infarction and stroke[J].J Mol Cell Cardiol, 2015, 80:146-155.
                            </a>
                        </p>
                        <p id="9">
                            <a id="bibliography_3" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=PZXX201707039&amp;v=MjU5OTZiWVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpuVjdyS05UZlRkckc0SDliTXFJOUc=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[3]</b>李中轩, 张颖倩, 陈韵岱.内皮祖细胞在缺血性心脏病治疗中的研究进展[J].中国循证心血管医学杂志, 2017, 9 (7) :873-875, 878.
                            </a>
                        </p>
                        <p id="11">
                            <a id="bibliography_4" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZWYY201813057&amp;v=MTY2ODc0SDluTnJJOUFZNFFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpuVjdyS1B6clNkN0c=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[4]</b>李丹萍.阿托伐他汀与瑞舒伐他汀治疗急性心肌梗死患者的临床效果以及安全性比较[J].中国现代药物应用, 2018, 12 (13) :102-103.
                            </a>
                        </p>
                        <p id="13">
                            <a id="bibliography_5" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=MDJB201803013&amp;v=MTI1Mjl1Wm1GeWpuVjdyS0tDbkJiTEc0SDluTXJJOUVaNFFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlo=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[5]</b>张兵.瑞舒伐他汀对稳定性冠心病患者内皮祖细胞的影响[J].牡丹江医学院学报, 2018, 39 (3) :47-48, 38.
                            </a>
                        </p>
                        <p id="15">
                            <a id="bibliography_6" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZHXX201505003&amp;v=MjI1NDl1Wm1GeWpuVjdyS1B5WFRkckc0SDlUTXFvOUZaNFFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlo=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[6]</b>中华医学会心血管病学分会, 中华心血管病杂志编辑委员会.急性ST段抬高型心肌梗死诊断和治疗指南[J].中华心血管病杂志, 2015, 43 (5) :380-394.
                            </a>
                        </p>
                        <p id="17">
                            <a id="bibliography_7" target="_blank" href="http://scholar.cnki.net/result.aspx?q=ANGPTL3 possibly promotes cardiac angiogenesis through improving proangiogenic ability of endothelial progenitor cells after myocardial infarction">

                                <b>[7]</b>Luo F, Wu P, Chen J, et al.ANGPTL3 possibly promotes cardiac angiogenesis through improving proangiogenic ability of endothelial progenitor cells after myocardial infarction[J].Lipids Health Dis, 2018, 17 (1) :184.
                            </a>
                        </p>
                        <p id="19">
                            <a id="bibliography_8" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XFXZ201807023&amp;v=MTc0MzdCdEdGckNVUjdxZlp1Wm1GeWpuVjdyS1BTdlRkTEc0SDluTXFJOUhaNFFLREg4NHZSNFQ2ajU0TzN6cXE=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[8]</b>李玉琳, 张言真子, 陈博雅, 等.白细胞介素-12基因缺陷促进内皮祖细胞浸润改善缺血再灌注后心肌损伤的研究[J].心肺血管病杂志, 2018, 37 (7) :677-681, 691.
                            </a>
                        </p>
                        <p id="21">
                            <a id="bibliography_9" target="_blank" href="http://scholar.cnki.net/result.aspx?q=2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation:The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Societ">

                                <b>[9]</b>Ibanez B, James S, Agewall S, et al.2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation:The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC) [J].Eur Heart J, 2018, 39 (2) :119-177.
                            </a>
                        </p>
                        <p id="23">
                            <a id="bibliography_10" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=GLYZ201807006&amp;v=MTk4NjZHNEg5bk1xSTlGWW9RS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqblY3cktJaUhTZEw=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[10]</b>王太昊, 岑运光.瑞舒伐他汀片治疗急性心肌梗死的临床研究[J].中国临床药理学杂志, 2018, 34 (7) :756-759.
                            </a>
                        </p>
                        <p id="25">
                            <a id="bibliography_11" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=GLYZ201802012&amp;v=MTI5NDl1Wm1GeWpuVjdyS0lpSFNkTEc0SDluTXJZOUVab1FLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlo=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[11]</b>夏明红, 胡春光, 吴陈欢.瑞舒伐他汀对急性心肌梗死大鼠心肌细胞凋亡及胱天蛋白酶-3基因表达的影响[J].中国临床药理学杂志, 2018, 34 (2) :134-136.
                            </a>
                        </p>
                        <p id="27">
                            <a id="bibliography_12" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZGCK201803001&amp;v=MDAxOTNJOUZaWVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpuVjdyS1B5cklaYkc0SDluTXI=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[12]</b>朱国腾, 褚现明, 田晶, 等.PCI围手术期瑞舒伐他汀强化治疗对其循环内皮祖细胞数量及功能的影响[J].中国临床研究, 2018, 31 (3) :289-293.
                            </a>
                        </p>
                        <p id="29">
                            <a id="bibliography_13" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=PZXX201801022&amp;v=MjMxOTVxcUJ0R0ZyQ1VSN3FmWnVabUZ5am5WN3JLTlRmVGRyRzRIOW5Ncm85SFpvUUtESDg0dlI0VDZqNTRPM3o=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[13]</b>谢静, 闵青.瑞舒伐他汀对急性心肌梗死患者PCI术后炎症因子和血液流变学的影响[J].中国循证心血管医学杂志, 2018, 10 (1) :82-84.
                            </a>
                        </p>
                        <p id="31">
                            <a id="bibliography_14" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=GAYX201802009&amp;v=MDMyOTc3cktJaXpTZHJHNEg5bk1yWTlGYllRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqblY=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[14]</b>谢亚芹, 赵娟, 康大伟, 等.不同剂量瑞舒伐他汀对急性心肌梗死大鼠心肌纤维化的影响及机制[J].广东医学, 2018, 39 (2) :195-198.
                            </a>
                        </p>
            </div>
        <!--reference end-->
        <!--footnote start-->
        <!--footnote end-->



    </div>

        <input id="fileid" type="hidden" value="XXGK201904017" />
        <input id="dpi" type="hidden" value="300" />
    </div>

<script>
var _hmt = _hmt || [];
(function() {
  var hm = document.createElement("script");
  hm.src = "https://hm.baidu.com/hm.js?6e967eb120601ea41b9d312166416aa6";
  var s = document.getElementsByTagName("script")[0];
  s.parentNode.insertBefore(hm, s);
})();
</script>

    


<input id="hid_uid" name="hid_uid" type="hidden" value="WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" />
<input id="hid_kLogin_headerUrl" name="hid_kLogin_headerUrl" type="hidden" value="/KLogin/Request/GetKHeader.ashx%3Fcallback%3D%3F" />
<input id="hid_kLogin_footerUrl" name="hid_kLogin_footerUrl" type="hidden" value="/KLogin/Request/GetKFooter.ashx%3Fcallback%3D%3F" />
<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201904017&amp;v=MDIzNjg2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpuVjdyS1BUWE1aYkc0SDlqTXE0OUVZNFFLREg4NHZSNFQ=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>
<div class="popflow" id="popupTips" style="display: none;">
    <div class="popflowArr"></div>
    <div class="popflowCot">
        <div class="hd"><a href="javascript:void(0);" onclick="$('#popupTips').hide();$('#popupmsg').html('')" class="close">X</a></div>
        <div class="bd">
            <p class="mes" id="popupmsg" name="popupmsg"></p>
          
        </div>
    </div>
</div>
<input type="hidden" id="myexport" value="//kns.cnki.net" />

<input type="hidden" id="KPCAPIPATH" value="//ishufang.cnki.net" />
<input type="hidden" id="CitedTimes" value="" />
<div class="link" id="GLSearch" style="display: none;">
    <i class="icon-trangle"></i>
    <div class="inner">
        <a class="icon" id="copytext">复制</a>
        <a class="icon" target="_blank" onclick="searchCRFD(this)">工具书搜索</a>
    </div>
</div>




<input id="hidVirtualPath" name="hidVirtualPath" type="hidden" value="/kxreader" />
<script src="/kxreader/bundles/detail?v=842_VlRz_g1CMCLi-M0twVw-4EOFG_noWyi_OsMnrAg1"></script>

<script src="/kxreader/Scripts/layer.min.js" type="text/javascript"></script>

<div id="footerBox" class="rootw footer">
</div>
<script>
    if (typeof FlushLogin == 'function') {
        FlushLogin();
    }
    modifyEcpHeader(true);
</script>

<!--图片放大功能 start-->
<script src="/kxreader/bundles/imagebox?v=W4phPu9SNkGcuPeJclikuVE3PpRyIW_gnfjm_19nynI1"></script>

<script type="text/javascript">
    $(function () {
        var j = $.noConflict();
        j(function () {
            j(".zoom-in,.btn-zoomin").imgbox({
                'alignment': 'center',
                'allowMultiple': false,
                'overlayShow': true
            });
        })
    });
</script>
<!--图片放大功能 end-->
<div class="fixedbar">
    <div class="backtop hiddenV" id="backtop">
        <a id="backTopSide" href="javascript:scroll(0,0);" title=""></a>
    </div>
</div>
<script type="text/javascript" src="/kxreader/Scripts/MathJax-2.6-latest/MathJax.js?config=MML_HTMLorMML-full"></script>

</body>
</html>
